Entyvio

Indicated For

Ulcerative Colitis, Crohn's Disease

About This Medication

# ENTYVIO® Complete Patient Guide: How to Get Entyvio (vedolizumab) at Low or No Cost ENTYVIO® Complete is Takeda's patient assistance program (PAP) designed to provide **Entyvio (vedolizumab)**—a biologic medication for treating moderate to severe ulcerative colitis and Crohn's disease—at little or no cost to eligible uninsured or underinsured patients.[1] This guide explains eligibility, the application process, and support options in simple terms to help you access this important treatment. ## About Entyvio and Why Assistance Matters **Entyvio (vedolizumab)** is an infusion or subcutaneous injection medication that targets inflammation in the gut without broadly suppressing the immune system, making it a targeted therapy for inflammatory bowel disease (IBD) like ulcerative colitis and Crohn's disease.[1][2] It's administered every 8 weeks after initial doses, often at an infusion center or self-injected at home with the ENTYVIO Pen.[3] The cost of Entyvio can be high—thousands per dose—creating barriers for many patients. ENTYVIO® Complete steps in for those without adequate insurance, reviewing applications case-by-case to provide free medication shipped to your doctor's office.[1] This program reflects Takeda's commitment to access, separate from their EntyvioConnect co-pay program for commercially insured patients.[2] ## Who Qualifies for ENTYVIO® Complete? Eligibility focuses on financial need and insurance status rather than strict income limits. You generally qualify if you are **uninsured or underinsured** and cannot afford Entyvio.[1] Applications are evaluated individually based on your circumstances.[1] ### Income Eligibility Breakdown Unlike many PAPs, ENTYVIO® Complete does not publish fixed income thresholds (e.g., percentages of the Federal Poverty Level). Instead, decisions are made case-by-case, prioritizing those with demonstrated financial hardship.[1] Here's a general overview: | Household Size | Typical Income Consideration | Notes | |---------------|------------------------------|--------| | Individual | Case-by-case; no fixed limit | Must prove inability to pay[1] | | Couple | Case-by-case; no fixed limit | Household income reviewed[1] | | Family of 3 | Case-by-case; no fixed limit | Includes dependents[1] | | Family of 4+ | Case-by-case; no fixed limit | Larger families may have flexibility[1] | **Key Point:** Submit proof of income and expenses for review. No specific FPL percentage is required, making it accessible for varying situations.[1] ## Insurance Requirements - **Uninsured patients** are prime candidates.[1] - **Underinsured patients** (e.g., high deductibles or coverage gaps) may qualify if insurance doesn't cover Entyvio adequately.[1] - **Medicare Part D patients** are eligible on a **case-by-case basis**—contact the program to check.[3] - Patients fully covered by insurance (where Entyvio is paid) typically do not qualify.[1] - Government programs like Medicaid or full Medicare often disqualify you, but exceptions apply.[2] Note: This PAP is distinct from EntyvioConnect's co-pay card, which is for commercial insurance only (up to $20,000/year savings, $5-$0 per dose).[2][9] ## Step-by-Step Application Process 1. **Discuss with Your Doctor:** Your healthcare provider must prescribe Entyvio and complete part of the application, confirming medical necessity.[1] 2. **Download the Form:** Get the official ENTYVIO PAP application from the manufacturer's site (linked via Entyvio HCP resources).[1] 3. **Gather Documents:** Provide proof of income (tax returns, pay stubs), insurance status (denial letters if applicable), and ID. Exact list not specified—program guides you.[1] 4. **Complete and Sign:** Patient, doctor, and infusion site sign, agreeing to terms like no resale and use of an exclusive pharmacy.[1] 5. **Submit:** Mail or fax the form (details on PDF). Multiple methods available.[1] 6. **Enroll in Support:** Opt into EntyvioConnect for nurse educators, injection training kits (for Pen), and tips.[3][6] Call 1-855-ENTYVIO (1-855-368-9846) Monday-Friday 8AM-8PM ET for help.[8][9] ## Timeline and Delivery Processing time varies as reviews are case-by-case—expect weeks, not days. Once approved, medication ships **directly to your physician's office or infusion site** via an exclusive noncommercial pharmacy.[1] Your doctor dispenses it to you. Refills require reauthorization (details below).[1] ## Alternatives if Denied - **Appeal:** Resubmit with more documentation or updated finances.[1] - **EntyvioConnect Co-Pay Program:** For commercial insurance—$0-$5/dose up to $20,000/year.[2][9] - **START Program:** Bridge coverage for insurance delays (up to 3 years, commercial only).[8] - **Takeda Help at Hand:** Broader assistance resources.[4] - **State Programs or Foundations:** Check PAN Foundation or similar for IBD support. - **Biosimilars:** None currently available.[program data] ## Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. Program terms can change; always verify with Takeda at 1-855-ENTYVIO or entyvio.com. Not medical advice—consult your doctor. Takeda may discontinue assistance anytime. Eligibility not guaranteed.[1][2]

Program information last verified: February 27, 2026